During the procedure patients may experience sensations of pulling, tugging, mild pinching, intense cold, tingling, stinging, aching and cramping at the treatment site. These sensations may subside as the area becomes numb. Following the procedure, typical side effects include redness, swelling, blanching, bruising, firmness, tingling, stinging, tenderness, cramping, aching, itching, skin sensitivity and numbness. Numbness can persist for up to several weeks. A sensation of fullness in the back of the throat may occur after submental treatment. These rare and very rare adverse events have the following reported rates (approximate occurrences per number of treatment cycles): paradoxical hyperplasia (1/3000 [0.033%]); late-onset pain (1/6000 [0.017%]); severe pain (1/6000 [0.017%]); hyperpigmentation (1/11000 [0.009%]); freeze burn (1/15000 [0.006%]); treatment area demarcation (1/20000 [0.005%]); vasovagal symptoms (1/30000 [0.003%]); subcutaneous induration (1/30000 [0.003%]); cold panniculitis (1/60000 [0.002%]) and hernia (1/185000 [0.001%]).¹ The CoolSculpting® procedure is not for everyone. Patients should not have the CoolSculpting® procedure if they suffer from cryoglobulinemia, cold agglutinin disease or paroxysmal cold haemoglobinuria.¹ The CoolSculpting® procedure is not a treatment for obesity.² CoolSculpting® is not a weight-loss procedure and should not replace a healthy diet and active lifestyle.
Treatment results may vary. All models shown have been treated with CoolSculpting®. You should always consult a healthcare professional to help you decide if CoolSculpting® is right for you and provide you with a full list of side effects.
References
1. Allergan. CoolSculpting® system user manual. BRZ-101-TUM-EN4-K. August 2020.
2. FDA 510(K) summary document, January 2020. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf19/K193566.pdf. [June 2024]
The suitability of CoolSculpting® treatment on an individual patient basis should always be considered as part of the assessment and consultation process. CoolSculpting® is not suitable for all patients. Please consult the ‘Directions for Use’ prior to the procedure. Patient results may vary.
To learn more about CoolSculpting® and/or CoolSculpting® Elite, please visit https://uk.coolsculpting.com/ for further information. Images are for illustrative purposes only. Promotional material provided by Allergan Aesthetics, an AbbVie company. This content is intended for UK & Ireland adult (>18yrs) audience only.
HCPs - Adverse Events should be reported.
UK Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App stores. Adverse events should also be reported to AbbVie on coolsculpting.intlsupport@allergan.com
Irish HCPs are asked to report any suspected adverse reactions via HPRA Pharmacovigilance website: https://www.hpra.ie.
Patient - Adverse events should be reported.
UK - Reporting of Side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can help by reporting side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie at coolsculpting.intlsupport@allergan.com. By reporting side effects, you can help provide more information on the safety of this product.
Ireland - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via https://www.hpra.ie.